Cargando…
Effect of Remote Ischaemic Conditioning on the Inflammatory Cytokine Cascade of COVID-19 (RIC in COVID-19): a Randomized Controlled Trial
PURPOSE: Patients hospitalized with COVID-19 may develop a hyperinflammatory, dysregulated cytokine “storm” that rapidly progresses to acute respiratory distress syndrome, multiple organ dysfunction, and even death. Remote ischaemic conditioning (RIC) has elicited anti-inflammatory and cytoprotectiv...
Autores principales: | Lukhna, Kishal, do Carmo, Helison R. P., Castillo, Alejandro Rossell, Davidson, Sean M., Geffen, Hayli, Giesz, Sara, Golforoush, Pelin, Bovi, Ticiane Gonçalez, Gorag, Diana, Salama, Alan, Imamdin, Aqeela, Kalkhoran, Siavash, Lecour, Sandrine, Perroud Jr., Mauricio W., Ntsekhe, Mpiko, Sposito, Andrei C., Yellon, Derek M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707178/ https://www.ncbi.nlm.nih.gov/pubmed/36445625 http://dx.doi.org/10.1007/s10557-022-07411-2 |
Ejemplares similares
-
RIC in COVID-19—a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19
por: Davidson, Sean M., et al.
Publicado: (2021) -
Correction to: RIC in COVID-19—a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19
por: Davidson, Sean M., et al.
Publicado: (2021) -
Remote Ischaemic Conditioning in STEMI Patients in Sub-Saharan AFRICA: Rationale and Study Design for the RIC-AFRICA Trial
por: Lukhna, Kishal, et al.
Publicado: (2021) -
Remote ischaemic conditioning: defining critical criteria for success—report from the 11th Hatter Cardiovascular Workshop
por: Bell, R. M., et al.
Publicado: (2022) -
Phenotypic changes in low-density lipoprotein particles as markers of adverse clinical outcomes in COVID-19
por: Carmo, Helison Rafael P., et al.
Publicado: (2023)